MANOLITO CASTILLO: Open Payments
NPI 1962585356 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 25 payments from 9 companies in 2025. Trend: 2023 $368 · 2024 $654 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 7 | $216 |
| Janssen Pharmaceuticals, Inc | 7 | $162 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Lundbeck LLC | 1 | $34 |
| ABBVIE INC. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: ARISTADA, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, COBENFY, REXULTI, VRAYLAR, Auvelity.
Industry payments across CA — which companies pay providers there.
